Secukinumab Provides Complete or Almost-Complete Psoriasis Clearance in Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of 4 Phase 3 Trials. J of Skin. 2018;2(S1):S19. doi:10.25251/skin.2.supp.19